Supreme plc (LON:SUP), a leading manufacturer, supplier, and brand owner of fast-moving consumer products, has announced a trading update for the twelve months ended 31 March 2023. Results for the period will be announced on Wednesday 5 July 2023.
Supreme has performed strongly throughout the second half of FY23, delivering organic growth across its core business, supplemented by the earnings from the two vaping acquisitions completed in the first half of the year.
The Company expects to report FY23 revenue of at least £150 million (2022: £130.8 million) and Adjusted EBITDA1 of at least £19.3 million (2022: £21.1 million), comfortably ahead of current market expectations2.
The Group’s Vaping category has delivered another excellent performance, nearly doubling revenues from £43.5 million in FY22 to around £75.0 million in FY23. This record performance, underpinned by the Group’s core 88Vape brand, has been buoyed by a number of earnings accretive acquisitions in the period, alongside strong new customer momentum, increased market share on e-liquids and favourable market conditions.
The remainder of the Group remains profitable and resilient with the Lighting category showing ongoing signs of recovery.
The Company expects bank borrowings net of cash to be neutral as at 31 March 2023, a reduction of £12.9 million since the half year, a reminder of the highly cash-generative nature of the Supreme platform.
Last week, Supreme was encouraged to hear of the Government’s continued support for Vaping as the “the most effective” smoking cessation tool and the launch of its national “swap to stop campaign” where the government plans to provide vape starter kits to support one million adults to quit smoking over the next two years. Supreme’s long-standing and overarching company strategy is to support a tobacco-free Great Britain by offering both credible and safer alternatives to nicotine consumption.
Outlook
Looking at FY24, the Group expects to maintain its strong growth trajectory, delivering another strong year of profitable growth. The Group now expects trading for the year ended 31 March 2024 to be slightly ahead of current market expectations3.
The Board remains confident that the Group will continue to deliver both organic and acquisition led growth this financial year and beyond.
1Adjusted EBITDA means operating profit before depreciation, amortisation, share-based payments charge, fair value movements on non-hedge accounted derivatives and exceptional items (including IPO-related costs).
2Company compiled analyst consensus for the year ending 31 March 2023 prior to release of this announcement were revenues of £138 million and Adjusted EBITDA of £18.5 million.
3Company compiled analyst consensus for the year ending 31 March 2024 prior to release of this announcement were revenues of £150.5 million and Adjusted EBITDA of £22.2million.
